世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038384

呼吸器診断市場‐2020-2030年の予測

Fatpos Global

Respiratory Diagnostics Market Opportunities And Future Trends For Forecast Year 2020-2030

発刊日 2024/04

言語英語

体裁Word-PDF/175ページ

ライセンス/価格175ページ

0000038384

Excel
Single
Multi
Global

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

市場概要

呼吸器診断とは、肺機能および関連するプロセスの臨床検査を指します。喘息、COPD、肺がん、気管支炎、肺線維症を検出するためのさまざまな機械的、放射線学的、分子的診断検査を網羅しています。肺活量測定、酸素濃度測定、経皮的CO2モニタリング、鼻吸気圧 (SNIP)、胸部X線、コンピューター断層撮影 (CT) スキャンなどの方法を使用します。睡眠研究は、睡眠時無呼吸症候群や夜間低換気の発生を特定し、分析するために使用されます。呼吸器診断の世界市場には、拡大の余地が大いにあります。近い将来、新規企業の参入により、競争が激化すると予想されます。競争に打ち勝つために、大手企業は製品の革新と技術開発に注力する可能性があります。

レポート詳細

目次

Contents

1. Executive Summary

2. Global Respiratory Diagnostics Market
 1. Product Overview
 2. Market Definition
 3. Segmentation
 4. Assumptions and Acronyms

3. Research Methodology
 1. Research Objectives
 2. Primary Research
 3. Secondary Research
 4. Forecast Model
 5. Market Size Estimation

4. Average Pricing Analysis

5. Macro-Economic Indicators

6. Market Dynamics
 1. Growth Drivers
 2. Restraints
 3. Opportunity
 4. Trends

7. Correlation & Regression Analysis
 1. Correlation Matrix
 2. Regression Matrix

8. Recent Development, Policies & Regulatory Ladscape

9. Risk Analysis
 1. Demand Risk Analysis
 2. Supply Risk Analysis

10. Global Respiratory Diagnostics Market Analysis
 1. Porters Five Forces
  1. Threat of New Entrants
  2. Bargaining Power of Suppliers
  3. Threat of Substitutes
  4. Rivalry
 2. PEST Analysis
  1. Political
  2. Economic
  3. Social
  4. Technological

11. Global Respiratory Diagnostics market
 1. Market Size & forecast, 2020A-2030F
  1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12. Global Respiratory Diagnostics Market: Market Sgmentation
 1. By Regions
  1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  4. Middle East and Africa: (Saudi Arabia, South Africa, UAE and rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  5. Latin America (Brazil, Mexico and Argentina, Rest of South America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
 2. By Product and Service Type: Market Share (2020-2030F)
  1. Instruments and Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. Services and Software, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
 3. By Test Type: Market Share (2020-2030F)
  1. Mechanical Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. Obstructive Sleep Apnoea (OSA) Diagnostic Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  3. Imaging Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  4. Traditional Diagnostic Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  5. Molecular Diagnostic Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  6. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
 4. By Disease: Market Share (2020-2030F)
  1. Tuberculosis, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. Asthma, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  3. Chronic Obstructive Pulmonary Disease (COPD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  4. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
 5. By End user: Market Share (2020-2030F)
  1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. Clinics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  3. Reference and Clinical Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile
1 Philips Healthcare
 1 Company Overview
 2 Company Total Revenue (Financials)
 3 Market Potential
 4 Global Presence
 5 Key Performance Indicators
 6 SWOT Analysis
 7 Product Launch
2 Abbott Laboratories
3 Biomerieux
4 Becton Dickinson
5 Thermo Fisher Scientific
6 Alere Inc.
7 Seegene Inc.
8 3M
9 Bio-Rad Laboratories
10 SDI Diagnostics
11 COSMED
12 Masimo Corporation
13 Other Prominent Players

この商品のレポートナンバー

0000038384

TOP